PRINT THIS PAGE

Etelint launches new technology venture fund with US and China focus

Etelint Capital Partners has announced the official launch of the Etelint Technology Venture Fund dedicated to invest in IT and life science companies. First Oxygen Ventures is the sole investor in the $25m fund, but the firm plans to increase the size of the fund to $50m next year.

‘We are pleased to announce the launch of Etelint Technology Venture Fund in this interesting business climate,’ said Charlene Pai, who heads Etelint Capital Partners. ‘There are so many companies in the IT and Life Science space just waiting for someone to be a constructive catalyst in the early stages of their company’s development or to provide them with the capital to accelerate their growth. With Etelint these companies have a dedicated and experienced team to turn to for both financing and assistance during those periods.’

Although the fund has no geographical restrictions, it is expected to make the majority of its investments in the US and China.

‘We are delighted to work with Etelint Capital Partners. Their experience and expertise in China is one of the reasons why First Oxygen Partners decided to make this strategic investment in their fund,’ said Haizat Latiff, general partner at First Oxygen. ‘We believe that there is a tremendous investment opportunity in China and together with Etelint, we expect to make good returns on the investments throughout the life of the fund.’

Etelint Capital Partners was formed in April 2000 and now has offices in ten cities around the world. The firm’s investment strategy focuses on technology repositioning. It relocates hi-tech companies from Asia, the US or Europe to international markets.

Copyright © 2003 AltAssets